3 unknown, 1 completed. 2 Not applicable, 2 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 2 | Unknown 2 |
| Phase 4 | 2 | Completed 1, Unknown 1 |
Follow Mei Han: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Clinical Study on the Treatment of Elevated Total Bilirubin in Primary Biliary Cholangitis With Baobao Dan Capsule Babaodan Capsule - Primary Biliary Cholangitis | Phase 4 | Unknown | Mei Han | 60 | 2024-04-25 | 2024-04-17 |
| Randomized Control Trial of Small-Molecule Natural Flavonoids Intervention for Neurodegenerative Diseases SMARTO ONE, placebo - Neurodegenerative Diseases | Not applicable | Unknown | Mei Han | 10 | 2023-08-15 | 2023-08-14 |
| Single Arm Clinical Trial of Small Molecule Natural Flavonoid Compounds for Intervention in Neurodegenerative Diseases SMARTO ONE - Neurodegenerative Diseases | Not applicable | Unknown | Mei Han | 30 | 2023-08-15 | 2023-08-14 |
| Changyanning Tablet for the Treatment of Diarrhea-Predominant Irritable Bowel Syndrome (IBS-D) Changyanning tablet, Changyanning tablet placebo - Diarrhea-Predominant Irritable Bowel Syndrome | Phase 4 | Completed | Mei Han | 240 | 2023-01-30 | 2026-07-14 |
Neurodegenerative Diseases (2) · Liver Cirrhosis, Biliary (1)
China (1)
Wei Wei, Pro (1)